Management of Tuberculous Epididymoorchitis
Treat tuberculous epididymoorchitis with a standard 6-month anti-tubercular regimen consisting of 2 months of intensive phase therapy (isoniazid, rifampicin, pyrazinamide, and ethambutol) followed by 4 months of continuation phase (isoniazid and rifampicin), with surgery reserved for specific complications or diagnostic uncertainty. 1, 2
Medical Management: First-Line Approach
The cornerstone of treatment is anti-tubercular chemotherapy, which should be initiated as soon as the diagnosis is established or strongly suspected:
Standard 6-Month Regimen 1
Intensive Phase (2 months):
- Isoniazid: 5 mg/kg daily (maximum 300 mg)
- Rifampicin: 10 mg/kg daily (maximum 600 mg)
- Pyrazinamide: 25 mg/kg daily (maximum 2000 mg)
- Ethambutol: 15-20 mg/kg daily (maximum 800-1600 mg depending on body weight)
Continuation Phase (4 months):
- Isoniazid: 5 mg/kg daily (maximum 300 mg)
- Rifampicin: 10 mg/kg daily (maximum 600 mg)
This regimen is adequate for genitourinary tuberculosis, including epididymoorchitis, as genital tract tuberculosis responds well to standard chemotherapy 2.
Role of Surgery
Surgery is not the primary treatment but has specific indications 3, 4, 5:
Surgical Indications:
- Diagnostic uncertainty when malignancy cannot be excluded (common scenario as TB can mimic testicular cancer) 6
- Large epididymal abscesses requiring drainage 7, 8
- Sinus tract formation or scrotal fistulas 4
- Failed medical therapy with persistent masses or symptoms
- Ill-defined epididymal-testicular border suggesting extensive local invasion 4
Surgical Approach - "Triple Therapy" 3:
When surgery is needed, the optimal approach combines:
- Pre-operative chemotherapy (2-4 weeks) to reduce bacterial load and inflammation 4
- Surgical intervention (epididymectomy alone if testis uninvolved; orchiectomy if testis extensively involved)
- Post-operative chemotherapy (3-6 months total duration from treatment start)
Important caveat: The study showing good outcomes with this triple therapy approach involved patients with advanced disease where diagnosis was uncertain 3. Most patients with confirmed TB epididymoorchitis should receive medical therapy first.
Diagnostic Confirmation
Before initiating treatment, attempt to establish microbiological diagnosis 1:
- Three consecutive early-morning first-void urine samples for acid-fast bacilli culture (though urine cultures are frequently negative in isolated genital TB) 3
- PCR testing on urine or genital secretions when available 9
- Aspiration cytology from epididymal collections if present 7
- Imaging (ultrasound, CT, MRI) to assess extent of disease and rule out disseminated TB 7, 9
Critical pitfall: Urine cultures are often negative in isolated genital TB (all 16 available cultures were negative in one surgical series) 3, so negative cultures should not delay treatment if clinical suspicion is high.
Multidrug-Resistant TB
If MDR-TB is suspected or confirmed, use an individualized regimen with at least 5 effective agents 1:
- One fluoroquinolone (Group A: levofloxacin, moxifloxacin, or gatifloxacin)
- One injectable agent (Group B: amikacin, capreomycin, kanamycin, or streptomycin)
- At least two from Group C (ethionamide/prothionamide, cycloserine/terizidone, linezolid, clofazimine)
- Add Group D agents if needed to reach five drugs
Follow-Up and Monitoring
- Regular follow-up is essential, though recurrence rates are low with appropriate therapy 3
- Monitor for complications: erectile dysfunction (4.9%), premature ejaculation (6.2%), and infertility (8.6%) can occur even with successful treatment 3
- Fertility counseling: Obstruction at multiple sites is characteristic and often not amenable to surgical reconstruction; assisted reproduction may be required 5
- Annual follow-up recommended long-term 5
Key Clinical Pearls
- Diagnosis is often delayed (mean 6.4 months from symptom onset) because presentation mimics bacterial epididymitis or testicular malignancy 3
- Beaded epididymal enlargement on examination is highly suggestive of TB 4
- Consider TB in any patient with persistent scrotal swelling unresponsive to antibiotics, especially with risk factors for TB exposure 7, 6
- Check for pulmonary and systemic TB as genitourinary involvement may be part of disseminated disease 7, 9